Alliance Healthcare — Revenue
Cencora Alliance Healthcare — Revenue decreased by 0.2% to $6.52B in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful market expansion, higher demand for pharmaceutical products in the served regions, or effective integration of distribution assets. A decrease may signal competitive pressure, regulatory pricing changes in European markets, or reduced volume in the pharmaceutical supply chain.
Detailed definition
This metric represents the total gross sales generated by the Alliance Healthcare segment, which focuses on pharmaceutic...
Peer comparison
Comparable to international distribution revenue segments at other global pharmaceutical wholesalers, such as the international segments of McKesson or Cardinal Health.
cor_segment_alliance_healthcare_revenueHistorical Data
| Q4 '24 | Q1 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|
| Value | $6.00B | $5.77B | $6.53B | $6.52B |
| QoQ Change | — | -3.8% | +13.1% | -0.2% |
| YoY Change | — | — | +8.9% | +12.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Cencora's alliance healthcare — revenue?
- Cencora (COR) reported alliance healthcare — revenue of $6.52B in Q1 2026.
- What does alliance healthcare — revenue mean?
- The total revenue generated by the company's international pharmaceutical wholesale and distribution business segment.